Hepatitis B virus (HBV) reactivation is commonly observed in individuals with chronic HBV infection undergoing antineoplastic drug therapy. Paclitaxel (PTX) treatment has been identified as a ...
Hepatitis B virus (HBV) reactivation is commonly observed in individuals with chronic HBV infection undergoing antineoplastic drug therapy. Paclitaxel (PTX) treatment has been identified as a ...
Chronic hepatitis B virus (HBV) infection remains a major cause of global liver morbidity, leading to progressive ...
Two cross-sectional, one validation cohort, and meta-analyses were used to explore the relationship between HBV replication and liver inflammation. Spearman analysis, multiple linear regression, and ...
PARIS — People with HIV and resolved HBV infection who switched from tenofovir-based antiretroviral therapy (ART) to tenofovir-sparing regimens did not see clinically meaningful hepatitis B virus (HBV ...
Mechanistic insights into how ROS-dependent Jak2/Stat3 activation initiates inflammatory responses during chronic HBV ...
As part of their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) can establish an infection in liver cells, researchers led by teams at Memorial Sloan ...
Hepatitis B virus (HBV) reactivation may occur if someone has chronic HBV, prior exposure to HBV and is undergoing treatment, or a health condition that suppresses their immune system. The hepatitis B ...
DR1-DR2 enrichment in HBeAg-negative chronic hepatitis B: integration hotspot or survivor signature?
We read with great interest the recent study by Lau et al , who reported distinct intrahepatic hepatitis B virus (HBV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results